June 6, 2014 — A new campaign from health and women's organizations urges FDA to approve a drug to treat sexual dysfunction in women, The Hill reports.
The organizations accuse FDA of "persistent gender inequality" for approving more than 20 drugs for sexual dysfunction in men and none for similar conditions in women. According to The Hill, FDA has refuted the accusations by highlighting the many women in leadership roles at the agency.
The debate involves a drug developed by Sprout Pharmaceuticals to treat hypoactive sexual desire disorder in women. FDA last year rejected a request to approve the drug because of concerns about its side effects, including nausea and fatigue.
The decision prompted backlash from women's organizations, some lawmakers and Sprout, which is backing the new campaign, called Even the Score (Viebeck, The Hill, 6/4).